Takeda Will Pay Up To $2.4B To Resolve Actos Suits
By Sindhu Sundar (April 28, 2015, 7:08 PM EDT) -- Takeda Pharmaceutical Co. Ltd. has agreed to pay up to $2.4 billion to resolve the "vast majority" of product liability suits over its diabetes drug Actos, which plaintiffs have claimed can increase the risks of developing bladder cancer, the Japanese drugmaker confirmed Tuesday.
Caption: Takeda Pharmaceutical Co. Ltd. has agreed to put $2.37 billion into a settlement fund if 95 percent of the plaintiffs and claimants targeting it opt in to the settlement, resolving the "vast majority" of product liability suits over its diabetes drug Actos. (Credit: AP) Takeda has agreed to put $2.37 billion into a settlement fund if 95...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!